354 related articles for article (PubMed ID: 32250173)
1. Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB.
Huang J; Li C; Song J; Velkov T; Wang L; Zhu Y; Li J
Future Microbiol; 2020 Apr; 15(6):445-459. PubMed ID: 32250173
[TBL] [Abstract][Full Text] [Related]
2. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
3. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Barrow K; Kwon DH
Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
[TBL] [Abstract][Full Text] [Related]
4. Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli.
Phan MD; Nhu NTK; Achard MES; Forde BM; Hong KW; Chong TM; Yin WF; Chan KG; West NP; Walker MJ; Paterson DL; Beatson SA; Schembri MA
J Antimicrob Chemother; 2017 Oct; 72(10):2729-2736. PubMed ID: 29091192
[TBL] [Abstract][Full Text] [Related]
5. Influence of PhoPQ and PmrAB two component system alternations on colistin resistance from non-mcr colistin resistant clinical E. Coli strains.
Wang CH; Siu LK; Chang FY; Tsai YK; Huang LY; Lin JC
BMC Microbiol; 2024 Apr; 24(1):109. PubMed ID: 38565985
[TBL] [Abstract][Full Text] [Related]
6. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
7. Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance.
Harris TL; Worthington RJ; Hittle LE; Zurawski DV; Ernst RK; Melander C
ACS Chem Biol; 2014 Jan; 9(1):122-7. PubMed ID: 24131198
[TBL] [Abstract][Full Text] [Related]
8. A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.
Chin CY; Gregg KA; Napier BA; Ernst RK; Weiss DS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7911-4. PubMed ID: 26459891
[TBL] [Abstract][Full Text] [Related]
9. PmrAB and PhoPQ Variants in Colistin-Resistant Enterobacter spp. Isolates in Korea.
Hong YK; Ko KS
Curr Microbiol; 2019 May; 76(5):644-649. PubMed ID: 30891622
[TBL] [Abstract][Full Text] [Related]
10. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
11. Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods.
Osei Sekyere J; Govinden U; Bester LA; Essack SY
J Appl Microbiol; 2016 Sep; 121(3):601-17. PubMed ID: 27153928
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Changes of Klebsiella pneumoniae in Response to Colistin Treatment and
Sun L; Rasmussen PK; Bai Y; Chen X; Cai T; Wang J; Guo X; Xie Z; Ding X; Niu L; Zhu N; You X; Kirpekar F; Yang F
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229491
[TBL] [Abstract][Full Text] [Related]
14. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
[TBL] [Abstract][Full Text] [Related]
15. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
Abraham N; Kwon DH
FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Investigation of the Signal Transduction Pathways Controlling Colistin Resistance in Klebsiella pneumoniae.
Cheung CHP; Dulyayangkul P; Heesom KJ; Avison MB
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457105
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
[TBL] [Abstract][Full Text] [Related]
19. Critical role of the RpoE stress response pathway in polymyxin resistance of Escherichia coli.
Zeng X; Hinenoya A; Guan Z; Xu F; Lin J
J Antimicrob Chemother; 2023 Mar; 78(3):732-746. PubMed ID: 36658759
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
